David Trainer On Why Mondelez International Is In The Danger Zone

CEO David Trainer sat down with Chuck Jaffe of Money Life and MarketWatch.com to talk about our Danger Zone pick this past week: Danger Zone: Mondelez International (MDLZ).


Stop us if you’ve heard this story before: slowing organic revenue growth, questionable non-GAAP metrics, and a large investment by activist Bill Ackman. No, we’re not talking about Valeant Pharmaceuticals (VRX), which is down 53% since we put it in the Danger Zone in late February. This time, we’re talking about Mondelez International (MDLZ).

Photo Credit: (Flickr)

Leave A Response

* Denotes Required Field